Skip to main content

Table 3 Results of modified FOLFOX-6 chemotherapy

From: Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

Response

No. of Pts (%)

Complete response

0 (0.0)

Partial response

32 (43.8)

Stable disease

21 (28.8)

Progressive disease

20 (27.4)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us